Current management of incidental gallbladder cancer: A review.
Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, Scanu AM, Porcu A.
Int J Surg. 2022 Feb;98:106234. doi: 10.1016/j.ijsu.2022.106234. Epub 2022 Jan 21.
Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer.
Wang J, Ren M, Yu J, Hu M, Wang X, Ma W, Jiang X, Cui J.
EBioMedicine. 2022 Nov;85:104319. doi: 10.1016/j.ebiom.2022.104319. Epub 2022 Oct 29.
Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.
Yuan B, Zhao X, Wang X, Liu E, Liu C, Zong Y, Jiang Y, Hou M, Chen Y, Chen L, Zhang Y, Wang H, Fu J.
Clin Transl Med. 2022 Jan;12(1):e678. doi: 10.1002/ctm2.678.
Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing.
Chen P, Wang Y, Li J, Bo X, Wang J, Nan L, Wang C, Ba Q, Liu H, Wang H.
Clin Transl Med. 2021 Jun;11(6):e462. doi: 10.1002/ctm2.462.
Malignant perivascular epithelioid cell tumor of the gallbladder: a case report and review of literature.
Zhao L, Anders KH.
Arch Pathol Lab Med. 2014 Sep;138(9):1238-41. doi: 10.5858/arpa.2013-0092-CR.
Malignant gastrointestinal stromal tumor of the gallbladder.
Park JK, Choi SH, Lee S, Min KO, Yun SS, Jeon HM.
J Korean Med Sci. 2004 Oct;19(5):763-7. doi: 10.3346/jkms.2004.19.5.763.
Gallbladder Cancer.
Waller GC, Sarpel U.
Surg Clin North Am. 2024 Dec;104(6):1263-1280. doi: 10.1016/j.suc.2024.03.006. Epub 2024 Apr 24.
Research progress on prognostic factors of gallbladder carcinoma.
Miao W, Liu F, Guo Y, Zhang R, Wang Y, Xu J.
J Cancer Res Clin Oncol. 2024 Oct 6;150(10):447. doi: 10.1007/s00432-024-05975-0.
Update on immunotherapy in the management of gallbladder cancer.
Kassab J, Saba L, Gebrael G, Kais S, Kassab R, Kourie HR.
Immunotherapy. 2023 Jan;15(1):35-42. doi: 10.2217/imt-2022-0191. Epub 2023 Jan 9.
MicroRNA-195-5p inhibits malignant progression of gallbladder cancer by regulating Wnt3a.
Sun HD.
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7635-7642. doi: 10.26355/eurrev_202112_27610.
